Dear Colleagues,
We are happy to announce the 2023 Duke-Industry Statistics Symposium (DISS2023), which will be held virtually on Zoom webinars on March 29-31, 2023. Attached is the draft program book. The direct link for registration is
https://sites.duke.edu/diss/register/.
DISS2023 has the theme
Empower Clinical Development by Harnessing Data from Diverse Sources. Clinical development commonly incorporates qualitative information outside of clinical trial settings in treatment evaluations and clinical assessments. Such qualitative information includes prior clinical experience and expert opinions. More recently, new study designs and methods that allow harnessing information from diverse sources of external data have been proposed. Leveraging external data sources, from historical trials in similar patient populations or with same-class treatments to real-world data and real-world evidence, is expected to drastically improve the efficiency of clinical developments.
The first day of the virtual symposium will be devoted to 4 short courses. The following day and a half will consist of 2 keynote speeches, 12 invited parallel sessions, and poster lightning talk sessions. Dr. John Concato, the Associate Director for Real-World Evidence Analytics in the Office of Medical Policy, FDA/CDER, will give a keynote speech on
Regulatory Perspectives on Real-World Data on March 30. Dr. Demissie Alemayehu, the Vice President of Pfizer Biostatistics, will give the second keynote speech on March 31 on
Enhancing Generalizability of Clinical Trial Results through Use of Real-World Evidence and Digital Solutions to Improve Enrollment Diversity. For updated information about the program schedule, including short courses, speakers, talk abstracts, poster submission, and registration, please visit
https://sites.duke.edu/diss.
The virtual symposium will be free to all undergraduate and graduate students with majors in statistics, biostatistics, and data sciences with viable credentials. The poster lightning talk sessions offer great opportunity for graduate students or young researchers to share their research work. The poster can be any topic that involves the use of quantitative methods in pharmaceutical developments.
The Duke-Industry Statistics Symposium is organized by the Department of Biostatistics and Bioinformatics, Duke University School of Medicine, and co-sponsored by Amgen, ASA-NC Chapter, BeiGene, Boehringer-Ingelheim, Genentech, ICSA, IQVIA, Janssen, Journal of Biopharmaceutical Statistics, Merck, Pfizer, PAREXEL, PPD (part of Thermo Fisher Scientific), SAS, UCB and ViiV. This series of symposiums was established ten years ago to discuss challenging issues and recent advances related to the clinical development of drugs, biologics, and devices and to promote research and collaboration among statisticians from industry, academia, and regulatory agencies.
We look forward to meeting you at the virtual event on March 29-31, 2023.
Sincerely yours,
The Organizing Committee of DISS2023
------------------------------
Xiaofei Wang
------------------------------